In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.

In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.

Reports of potential drug-resistant strains of Plasmodium malariae in western Indonesia raise concerns that chloroquine resistance may be emerging in P. malariae and P. ovale. In order to assess this, in vivo and in vitro efficacy studies were conducted in patients with monoinfection in Papua, Indon...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Siswantoro, H, Russell, B, Ratcliff, A, Prasetyorini, B, Chalfein, F, Marfurt, J, Kenangalem, E, Wuwung, M, Piera, K, Ebsworth, E, Anstey, N, Tjitra, E, Price, R
Natura:	Journal article
Lingua:	English
Pubblicazione:	2011

Documenti analoghi

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
di: Ratcliff, A, et al.
Pubblicazione: (2007)

Alternative treatment options for chloroquine resistant Plasmodium vivax in Papua, Indonesia
di: Price, R, et al.
Pubblicazione: (2005)

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
di: Hasugian, A, et al.
Pubblicazione: (2009)

Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
di: Ratcliff, A, et al.
Pubblicazione: (2007)

Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
di: Marfurt, J, et al.
Pubblicazione: (2011)

Efficacy of existing antimalarial drugs for uncomplicated malaria in Timika, Papua, Indonesia
di: Siswantaro, H, et al.
Pubblicazione: (2006)

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
di: Price, R, et al.
Pubblicazione: (2010)

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
di: Suwanarusk, R, et al.
Pubblicazione: (2007)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
di: Karyana, M, et al.
Pubblicazione: (2008)

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
di: Rossarin Suwanarusk, et al.
Pubblicazione: (2007-10-01)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
di: Hasugian, A, et al.
Pubblicazione: (2007)

Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
di: Wirjanata, G, et al.
Pubblicazione: (2015)

Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
di: Russell, B, et al.
Pubblicazione: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
di: Tjitra, E, et al.
Pubblicazione: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
di: Tjitra, E, et al.
Pubblicazione: (2008)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant <it>Plasmodium vivax </it>and <it>Plasmodium falciparum</it>
di: Okoseray Maurits J, et al.
Pubblicazione: (2008-08-01)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
di: Yeo, T, et al.
Pubblicazione: (2010)

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
di: Marfurt, J, et al.
Pubblicazione: (2021)

Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
di: Marfurt, J, et al.
Pubblicazione: (2011)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia
di: Lampah, D, et al.
Pubblicazione: (2011)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
di: Karyana, M, et al.
Pubblicazione: (2007)

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.
di: Price, R, et al.
Pubblicazione: (2007)

Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.
di: Suwanarusk, R, et al.
Pubblicazione: (2008)

Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia.
di: Maguire, G, et al.
Pubblicazione: (2005)

Plasmodium vivax infection: A major determinant of severe anaemia in Papua, Indonesia
di: Price, R, et al.
Pubblicazione: (2007)

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia
di: Kho, S, et al.
Pubblicazione: (2018)

In vitro and molecular characterisation of multidrug resistant Plasmodium vivax.
di: Suwanarusk, R, et al.
Pubblicazione: (2008)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
di: Tjitra, E, et al.
Pubblicazione: (2007)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
di: Setyadi, A, et al.
Pubblicazione: (2019)

Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.
di: Salwati, E, et al.
Pubblicazione: (2011)

Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia
di: Karyana, M, et al.
Pubblicazione: (2016)

New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
di: Price, R, et al.
Pubblicazione: (2009)

Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
di: Maguire, J, et al.
Pubblicazione: (2006)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.
di: Douglas, N, et al.
Pubblicazione: (2014)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
di: Thriemer, K, et al.
Pubblicazione: (2020)

Impaired endothelial function in adults with severe falciparum malaria in Papua, Indonesia
di: Yeo, T, et al.
Pubblicazione: (2006)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
di: Rahmalia, A, et al.
Pubblicazione: (2019)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
di: Agus Setyadi, et al.
Pubblicazione: (2019-04-01)

Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia
di: Getachew, S, et al.
Pubblicazione: (2015)

Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
di: Marfurt, J, et al.
Pubblicazione: (2012)